Novartis
NVS
$98.60
Share price
-1.06%
Change (1 day)
11.20%
Change (1 year)
Categories
Novartis AG is a biotechnology and pharmaceutical company based in Basel, Switzerland. Novartis was formed in 1996 from a merger of the two Basel pharmaceutical and chemical companies Ciba-Geigy AG and Sandoz AG. Novartis is one of the largest pharmaceutical companies in the world with sales of USD 47.4 billion in 2019.
Novartis (NVS) - Net assets
Net assets on the balance sheet as of March 2023 : $52.14 B
According to Novartis's latest financial reports the company has $52.14 B in net assets.
A company’s net assets is the sum of its assets minus the sum of its liabilities.
Novartis - Net assets on balance sheet (from 2001 to 2023)
Net assets by year
| Year | Net assets | Change |
|---|---|---|
| 2022-12-31 | $59.42 B | -12.38% |
| 2021-12-31 | $67.82 B | 19.69% |
| 2020-12-31 | $56.66 B | 2.01% |
| 2019-12-31 | $55.55 B | -29.41% |
| 2018-12-31 | $78.69 B | 6.02% |
| 2017-12-31 | $74.22 B | -0.89% |
| 2016-12-31 | $74.89 B | -2.89% |
| 2015-12-31 | $77.12 B | 8.86% |
| 2014-12-31 | $70.84 B | -4.87% |
| 2013-12-31 | $74.47 B | 7.59% |
| 2012-12-31 | $69.21 B | 4.97% |
| 2011-12-31 | $65.94 B | -5.49% |
| 2010-12-31 | $69.76 B | 21.42% |
| 2009-12-31 | $57.46 B | 13.93% |
| 2008-12-31 | $50.43 B | 2.11% |
| 2007-12-31 | $49.39 B | 19.62% |
| 2006-12-31 | $41.29 B | 24.51% |
| 2005-12-31 | $33.16 B | -2.23% |
| 2004-12-31 | $33.92 B | 11.15% |
| 2003-12-31 | $30.51 B | 7.42% |
| 2002-12-31 | $28.41 B | 11.16% |
| 2001-12-31 | $25.55 B |
Net assets for similar companies or competitors
| Company | Net assets | differencediff. | Country |
|---|---|---|---|
 Johnson & Johnson JNJ | $76.80 B | 47.30% | 🇺🇸 USA |
 Pfizer PFE | $95.91 B | 83.95% | 🇺🇸 USA |
 Abbott Laboratories ABT | $36.90 B | -29.22% | 🇺🇸 USA |
 Sanofi SNY | $80.48 B | 54.36% | 🇫🇷 France |
 Merck MRK | $46.05 B | -11.67% | 🇺🇸 USA |
 Bristol-Myers Squibb BMY | $31.88 B | -38.85% | 🇺🇸 USA |
 AstraZeneca AZN | $35.81 B | -31.32% | 🇬🇧 UK |
 GlaxoSmithKline GSK | $14.01 B | -73.13% | 🇬🇧 UK |
 Teva Pharmaceutical Industries TEVA | $8.69 B | -83.33% | 🇮🇱 Israel |